文献速递细菌感染、耐药与抗菌药物医院感染防控

美国联邦医疗保险与医疗补助服务中心脓毒症核心措施对抗生素使用的影响

Impact of the Centers for Medicare and Medicaid Services Sepsis Core Measure on Antibiotic Use.
PubMed 文献 · Clin Infect Dis · 2021-01-01

该研究评估了2015年CMS脓毒症核心措施(SEP-1)实施对广谱抗生素使用和艰难梭菌感染率的影响。

要点

  • SEP-1实施与医院获得性/多重耐药菌广谱抗生素使用立即和长期增加相关。
  • SEP-1实施时总体抗生素使用立即增加1.4%。
  • CDI率在SEP-1实施时意外下降。

核心结论

  • SEP-1实施与医院获得性/多重耐药菌广谱抗生素的立即和长期增加相关。
  • 抗菌药物管理项目应评估脓毒症治疗中降阶梯治疗的机会。

研究设计与样本

  • 研究纳入111家参与Clinical Data Base Resource Manager的医院。
  • 采用分段中断时间序列分析,使用负二项回归评估抗生素类别使用和CDI率的变化。

主要发现

  • CDI率在SEP-1实施时意外下降。
  • 限于脓毒症患者分析时,SEP-1实施时所有抗生素类别使用均显著增加。

临床怎么用

  • 抗菌药物管理项目应关注脓毒症治疗中广谱抗生素的降阶梯治疗机会。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Centers for Medicare and Medicaid Services (CMS) implemented a core measure sepsis (SEP-1) bundle in 2015. One element was initiation of broad-spectrum antibiotics within 3 hours of diagnosis. The policy has the potential to increase antibiotic use and Clostridioides difficile infection (CDI). We evaluated the impact of SEP-1 implementation on broad-spectrum antibiotic use and CDI occurrence rates. METHODS: Monthly adult antibiotic data for 4 antibiotic categories (surgical prophylaxis, broad-spectrum for community-acquired infections, broad-spectrum for hospital-onset/multidrug-resistant [MDR] organisms, and anti-methicillin-resistant Staphylococcus aureus [MRSA]) from 111 hospitals participating in the Clinical Data Base Resource Manager were evaluated in periods before (October 2014-September 2015) and after (October 2015-June 2017) policy implementation. Interrupted time series analyses, using negative binomial regression, evaluated changes in antibiotic category use and CDI rates. RESULTS: At the hospital level, there was an immediate increase in the level of broad-spectrum agents for hospital-onset/MDR organisms (+2.3%, P = .0375) as well as a long-term increase in trend (+0.4% per month, P = .0273). There was also an immediate increase in level of overall antibiotic use (+1.4%, P = .0293). CDI rates unexpectedly decreased at the time of SEP-1 implementation. When analyses were limited to patients with sepsis, there was a significant level increase in use of all antibiotic categories at the time of SEP-1 implementation. CONCLUSIONS: SEP-1 implementation was associated with immediate and long-term increases in broad-spectrum hospital-onset/MDR organism antibiotics. Antimicrobial stewardship programs should evaluate sepsis treatment for opportunities to de-escalate broad therapy as indicated.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Pakyz AL, Orndahl CM, Johns A, et al. Impact of the Centers for Medicare and Medicaid Services Sepsis Core Measure on Antibiotic Use. Clin Infect Dis. 2021. PMID: 32827032. doi:10.1093/cid/ciaa456

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。